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a  b  s  t  r  a  c  t
Infections  caused  by Streptococcus  pneumoniae  are  one  of  the  main  causes  of death  around  the world.  In
order to  address  this  problem,  investigations  are  being  made  into  the development  of  a  protein-based
vaccine.  The  aims  of  this  study  were  to clone  and  express  ClpP,  a  protein  from  S.  pneumoniae  serotype
14  in  Escherichia  coli,  to  optimize  protein  expression  by using  experimental  design  and  to  study  plasmid
segregation  in  the  system.  ClpP  was  cloned  into  the  pET28b  vector  and  expressed  in E. coli  BL21  Star  (DE3).
Protein expression  was  optimized  by  using  central  composite  design,  varying  the  inducer  (IPTG)  and
kanamycin  concentration,  with  a subsequent  analysis  being  made  of the  concentration  of  heterologous
protein,  cell  growth  and  the  fraction  of  plasmid-bearing  cells.  In  all  the  experiments,  approximately
the  same  concentration  of  ClpP  was  expressed  in  its soluble  form,  with  a mean  of  240.4  mg/L  at  the
center  point.  Neither  the  IPTG  concentration  nor  the  kanamycin  concentration  was  found  to  have  any
statistically  signiﬁcant  inﬂuence  on  protein  expression.  Also,  higher  IPTG  concentrations  were  found  to
have a negative  effect  on  cell  growth  and  plasmid  stability.  Plasmid  segregation  was  identiﬁed  in  the
system  under  all  the  concentrations  studied.  Using  statistical  analysis,  it  was  possible  to ascertain  that
the procedures  for determining  plasmid  stability  (serial  dilution  and  colony  counting)  were  reproducible.
It  was  concluded  that  the  inducer  concentration  could  be  reduced  tenfold  and  the  antibiotic  eliminated
signiﬁfrom  the  system  without  
costs.
. Introduction
Infections caused by Streptococcus pneumoniae are among the
ain causes of death in the world. This gram-positive, encapsu-
ated bacterium is the main cause of bacterial pneumonia and
s often implicated in other diseases such as otitis, sinusitis and
eningitis, as well as septicemia and bacteremia [1–4]. In recent
ears, an increasing number of strains have shown resistance to
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Open access under the Elsevier OA license.cantly  affecting  expression  levels  and  with  the  positive  effect  of  reducing
© 2011 Elsevier Ltd. 
different kinds of antibiotics, making the treatment of pneumo-
coccal pneumonia infections a major public health issue [1,3]. At
the present time there are two kinds of vaccines available on the
world market against S. pneumoniae: polysaccharide vaccines and
conjugate vaccines. Polysaccharide vaccines are made from the cap-
sular polysaccharides of S. pneumoniae, but their protection period
is limited and they are not very effective on children under 2 years
of age or with a compromised immune system [2,4,5].  Conjugate
vaccines, made from capsular polysaccharides conjugated to pro-
teins [6],  have proved effective with children and adults. However,
they are limited to certain serotypes and are very expensive [5,7].
In recent years several groups have been investigating different
Open access under the Elsevier OA license.proteins associated with this bacteria for their potential use in a
protein-based vaccine with broader effectiveness at a lower cost
[1,2,5,7–10].  One such protein with the potential to be used as an
antigen for a vaccine is the protease ClpP, which appears well con-
cine 2
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erved and prevalent among the different S. pneumoniae serotypes.
lpP is known as a heat shock protein, which protects bacteria
gainst adverse effects caused by elevated temperatures (for exam-
le), raising their survival levels. Mutant strains of S. pneumoniae in
his protein become less virulent, and immunizations of mice using
lpP show that it can provide protection against pneumococcal
nfections [11,12].
In order to obtain high concentrations of recombinant pro-
eins in soluble form and also reduce production costs, the many
ariables that inﬂuence the expression of these proteins must be
nderstood and controlled. The strategy of assessing one factor
t a time while keeping the others constant may  not be efﬁcient,
s it fails to take account of the interaction between the process
ariables and more experiments have to be done to obtain the
nformation required. The best approach is to use experimental
esign, which can be used to assess the effect and interaction of the
ariables involved, yielding the maximum amount of information
rom a minimum of experiments, while also allowing experimental
rrors to be assessed in order to enhance process effectiveness [13].
In recombinant bioprocesses, antibiotics like kanamycin are
idely used on a bench scale to put selective pressure on the cul-
ure medium, preventing plasmid segregation, since most of the
lasmids used have an antibiotic resistance marker gene. Plasmid
egregation may  have an impact on the recombinant protein yield,
specially on an industrial scale. However, the use of these antibi-
tics is unfeasible on an industrial scale because they are costly and
lso contaminate the product and have to be completely removed
n the food or drug puriﬁcation process [14]. This is why studying
he antibiotic concentration used in recombinant processes is so
mportant, even though the variation of the antibiotic in the cul-
ure may  affect plasmid stability. Another important variable in
he process, especially on a large scale, is the inducer used in the
xpression system, since some inducers, like IPTG, are expensive
nd may  be toxic to the host cell [15,16].
In view of these considerations, the aim of this study was  to clone
nd express ClpP using Escherichia coli as a host, optimize protein
roduction using experimental design and study the plasmid sta-
ility of the system. As such, central composite design was used
or two variables: concentration of the inducer of the recombinant
ystem (IPTG) and the concentration of the antibiotic (kanamycin)
n the culture medium.
. Materials and methods
.1. Bacterial strains
E. coli TOP 10 (Invitrogen) was used as the host for the cloning
rocedures. E. coli BL21 Star (DE3)TM (Invitrogen) was  used as the
acteria for expressing the recombinant protein ClpP.
.2. Chemicals
BactoTM yeast extract and tryptone were purchased from BD
Becton, Dickinson and Company), the glucose and NaCl were from
erck, the glycerol was  from Invitrogen, the kanamycin was from
igma and the IPTG (isopropyl -d-1-thiogalactopyranoside) was
urchased from Promega.
.3. PCR and cloning
The gene that codiﬁes protein ClpP was ampliﬁed by PCR
sing genomic DNA from S. pneumoniae serotype 14 (strain
13/95 deposited at Instituto Adolfo Lutz) as a template. The
rimers used were: 5′-CCCATGGTTCCTGTAGTTATTGAACAAAC-3′
nd 5′-CACTCGAGGTTCAATGAATTGTTGGC-3′. The NcoI and XhoI
estriction sites are underlined in the forward and reverse primers,9 (2011) 7136– 7143 7137
respectively. The PCR product was  digested by enzymes NcoI
and XhoI and inserted into the vector pET28b (Novagen). The
E. coli TOP10 strain was transformed by electroporation with
the constructed plasmid (pET28b/clpP). The constructed plasmid
pET28b/clpP was  conﬁrmed by digestion and sequenced with ﬂu-
orescent terminators (Big Dye, Applied Biosystems) using the ABI
PRISM® 3100 Genetic Analyzer (Applied Biosystems). Once ana-
lyzed, the plasmid was transformed into E. coli BL21 Star (DE3)TM.
2.4. Cell viability test
The cell viability of the stock of recombinant E. coli BL21 Star
(DE3)TM/pET28b/clpP in LB (5 g/L yeast extract, 10 g/L tryptone,
5 g/L NaCl, pH 7) with 25% glycerol, stored at −70 ◦C, was  assessed
by counting the colony forming units (CFUs) for all the experimen-
tal design experiments. Serial dilutions were made in PBS pH 7.4
and transferred to Petri plates containing LB Agar and 50 g/mL
kanamycin (concentration of stocks around 1010 CFU/mL).
2.5. Expression and solubility test
Recombinant E. coli BL21 Star (DE3)TM/pET28b/ClpP was pre-
inoculated (10 L) in 10 mL  of the LB medium enriched with 1%
glucose, 0.4% glycerol and 50 g/mL kanamycin. The pre-inoculum
was  incubated for 16 h at 37 ◦C and 200 rpm in 50 mL  ﬂasks under
agitation.
The inoculum was prepared in 500 mL ﬂasks with 2 mL  pre-
inoculum and 100 mL  of the LB medium enriched with 1% glucose,
0.4% glycerol and different kanamycin concentrations according to
the experimental design (as described in the next section). The
culture was  incubated at 37 ◦C and 200 rpm until it reached the
exponential growth phase (Abs600 nm between 0.65 and 0.75).
At this point, expression was  induced with IPTG for 4 h under
different induction concentrations according to the experimental
design. E. coli BL21 (DE3) Star/pET28a was used as a negative con-
trol.
1 mL  samples were taken from each experiment before and after
the 4 h expression period to assess cell growth, ClpP expression (by
SDS-PAGE) and solubility.
The cells were harvested by centrifugation at 20,817 × g for
5 min  to separate the culture medium. In order to assess the solu-
bility of the expressed protein the cells were resuspended in a lysis
buffer (20 mM  Tris, 1 mM EDTA, pH 8.0) at a ratio of 25 L buffer to
each 0.1 of Abs600 nm (normalizing to Abs600 nm), to obtain the
total protein extract. The total extract was  put through ﬁve 10 s
ultrasound cycles at 30% amplitude in an ultrasonic cell disruptor
(Sonics & Materials, Inc.). The soluble and insoluble fractions of the
total protein were separated from the cultures by centrifugation
(20,817 × g for 10 min  at 10 ◦C). The samples were added to 12%
SDS-PAGE [17], stained with Coomassie Blue R-250.
2.6. Experimental design
The inﬂuence of kanamycin and IPTG concentration on cell
growth, the concentration of expressed protein and plasmid sta-
bility was assessed by using a central composite design for two
variables. Eight experiments were performed, four of which were
replications at the center point (CP), as described in the previ-
ous section. The expression cultures were prepared using different
concentrations of kanamycin and were then induced with differ-
ent concentrations of IPTG as shown in the details of the central
composite design experiments in Table 1.
The statistical analyses were performed using STATISTICA 9.1
software (Statsoft), using the normalized variables. The effect of
each variable was  estimated, as was standard error, and was
7138 K. Einsfeldt et al. / Vaccine 29 (2011) 7136– 7143
Table  1
Central composite design and its response variables.
Run IPTG
(mM)
Kanamycin
(g/mL)
Dry mass of
cells (mg/L)
ClpP
(mg/L)
 ˚ (Fraction of
plasmid-bearing cells)
1 0.1 0 905.4 247.3 0.37
2 0.1  50 867.2 251.1 0.56
3  1 0 706.4 271.6 0.05
4  1 50 761.8 225.9 0.11
5  (CP) 0.55 25 744.6 266.3 0.08
6  (CP) 0.55 25 723.6 244.2 0.18
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Fig. 1. Diagram used for statistical evaluation of serial dilution and colony counting
procedures. This evaluation was performed on the experiments at the center point
(5,  6, 7 and 8) in LB agar plates with and without the antibiotic. A1 and A2 represent
aliquots 1 and 2, respectively, taken from the culture after 4 h expression to per-
form serial dilution. D2 represents the level of dilution obtained between 0 and 107  (CP) 0.55 25 766.7 229.7 0.07
8  (CP) 0.55 25 759.8 221.2 0.11
ssessed by the t-test, with all results giving p < 0.05 being con-
idered statistically signiﬁcant.
.7. Analysis of expression by SDS-PAGE using densitometry and
ssessment of cell growth
Cell growth was measured by absorbance at 600 nm.  This
as converted to dry mass of cells using a standard calibra-
ion curve. Samples of cells from 1 mL  culture were resuspended
n a sample buffer (60 mM Tris–HCl, pH 6.8, 10% glycerol, 5%
-mercaptoethanol, 2% SDS, 0.5% Bromophenol Blue) to obtain
he total protein extract, at a ratio of 25 L buffer to each 0.1
bs600 nm.  These samples were added to 12.5% SDS-PAGE [17],
tained with Coomassie Blue R-250. The same gel also had 2 L
ow molecular weight marker (LMW,  Amersham Bioscience) added,
ith 97 kDa, 66 kDa, 45 kDa, 30 kDa, 20.1 kDa and 14.4 kDa bands
nd 1340 ng, 1660 ng, 2940 ng, 1660 ng, 1600 ng and 2320 ng pro-
ein weight in each band, respectively, for the purpose of comparing
ith the bands corresponding to ClpP. The amount of protein
xpressed under each condition was analyzed by densitometry
sing a Bio-Rad GS-800 calibrated densitometer and Quantity-
ne 4.4.1 software. The concentration of expressed protein was
btained using the ratio (mg/L) = (Abs600 nm × band in densitome-
ry)/4, where 4 was the concentration factor used in the preparation
f the total protein extract samples.
.8. Plasmid stability analysis
In order to analyze plasmid segregation, 100 L samples were
aken from each experiment at the end of the 4 h expression period,
ith analysis done on two aliquots from each experiment. Each
liquot was serially diluted in sterile PBS to 10−6 (Fig. 1). 10 L
amples of each dilution with at least three replications were added
o LB Agar plates with kanamycin (50 g/mL) and without it. Plas-
id  stability was measured as the fraction of plasmid-bearing cells
˚) by calculating the ratio between the number of colony forming
nits (CFU/mL) on the plate with the antibiotic and on the plate
ithout the antibiotic.
A statistical evaluation was made with the aim of checking the
eproducibility and variability of the procedures for assessing plas-
id  stability (serial dilution and colony count). Student’s t-test was
sed to ﬁnd out whether the mean values from the colony count
ere equivalent, while the F-test (Fisher) was used to ﬁnd out
hether the errors made at each stage of the count were equiva-
ent. These tests were done using the values obtained from CFU/mL
n the experiments at the center point of the experimental design,
omparing different aliquots diluted to the same degree from the
ame culture, and the same aliquots diluted to different degrees
rom the same culture, as shown in the diagram in Fig. 1.In order to do the F-test, F was calculated using Eq. (1):
xy = 
2
x
2y
(1)colonies. D1 represents the dilution obtained between 10 and 100 colonies. C1, C2,
C3  and C4 are replications of CFU/mL. 21, 22, 23 and 24, represent the variances
of CFU/mL obtained in A1D1, A1D2, A2D1 and A2D2, respectively.
where 2x and 
2
y are the variances obtained for the different
CFU/mL counts, as shown in Fig. 1. The variances were considered
to be statistically equivalent when Fxy was between the conﬁ-
dence limits set (95% conﬁdence level) as described by Fisher’s
F-distribution [18].
The conﬁdence intervals for the mean were obtained using the
t-test as shown by Eq. (2):
Cl[]95% = x¯ ± t
s√
n
(2)
where  is the estimated mean population (95% conﬁdence), x¯  is
the sample mean, t is the value described by the Student’s t distri-
bution, s is standard deviation, and n is the sample size. The means
were regarded as statistically equivalent if the conﬁdence intervals
crossed.
2.9. Validation of experimental design
Having conducted the analyses of the experimental design,
replications were performed of the optimal cultivation condition to
validate the results obtained from the experimental design. Once
the cultures were induced, samples were taken every hour to assess
the ClpP protein production rate, cell growth and plasmid segrega-
tion.
3. Results and discussion
3.1. Expression and solubility
ClpP was expressed in E. coli BL21 Star (DE3)TM by induction with
IPTG. At the end of the expression period samples were taken for
the preparation of protein extracts, and the soluble and insoluble
fractions of the total protein were also separated out. These sam-
ples were analyzed using SDS-PAGE, as shown in Fig. 2. The ClpP
protein was not expressed in the negative control using E. coli BL21
(DE3) Star/pET28a. The results show that the size of ClpP expressed
was  as expected (22.4 kDa), as can be seen from the gel between
bands 18.4 kDa and 24 kDa of the molecular weight marker. Also,
the band that corresponds to ClpP cannot be seen before expression
was  induced (non-induced sample), as the RNA polymerase of bac-
teriophage T7 was used in the system, which is highly regulated and
repressed by the glucose added to the culture medium, only allow-
ing the recombinant protein to be expressed when the inducer was
K. Einsfeldt et al. / Vaccine 29 (2011) 7136– 7143 7139
Fig. 2. SDS-PAGE analysis of ClpP expression in E. coli BL21 Star (DE3). M,  molecular
weight marker; 1, sample of uninduced culture; 2, total protein extract after 4 h
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Table 3
Effects of variables on ClpP concentration (mg/L).
Effects Standard error t(4) p-value
Mean 244.69 6.41 38.14 <0.0001nduction; 3, insoluble fraction of total protein after 4 h induction; 4, soluble fraction
f total protein after 4 h induction. The samples added to the gel were normalized
o  Abs600 nm.
dded. The solubility analysis (Fig. 2) shows that the protein was
xpressed in a soluble form in high concentrations and that no
nclusion bodies were formed. It is known that one of the prob-
ems associated with overexpressing heterologous proteins in this
acterial cytoplasm is the formation of insoluble protein aggregates
inclusion bodies) caused by the mal-conformation of the protein
19,20]. This problem was not identiﬁed in the study in question.
.2. Experimental design: inﬂuence of the concentration of IPTG
nd kanamycin on cell growth, ClpP expression and plasmid
egregation
Experimental design was used to assess the inﬂuence of the
oncentration of IPTG and kanamycin on cell growth, protein pro-
uction and plasmid segregation. The conditions for each of the
entral composite design experiments are shown in Table 1, as are
he responses of the dependent variables under analysis.
.2.1. Effect of variables on cell growth
The effects of IPTG and kanamycin on cell growth are shown in
able 2. By analyzing these effects it was possible to infer, within the
5% conﬁdence interval, that the IPTG concentration had a signiﬁ-
ant negative inﬂuence on cell growth. Some authors have already
eported on the fact that IPTG is toxic and that in high concen-
rations it can drastically reduce cell growth in some cultures of
ecombinant E. coli [16,21–24].  Meanwhile, the kanamycin concen-
ration and the interaction of IPTG with kanamycin was  not found
o have any appreciable effect on cell growth within the ranges
nder study.
.2.2. Effect of variables on ClpP Production
The protein concentration stayed at similar levels under all the
onditions tested in the factorial design (Table 1). This means that
hen the effects of the variables on protein concentration were
nalyzed, it could be concluded that neither the IPTG concentration
or the kanamycin concentration nor the interaction of IPTG with
anamycin had any appreciable inﬂuence on protein expression in
able 2
ffects of variables on cell growth (mg/L of dry mass of cells).
Effect Standard error t(4) p-value
Mean 779.43 16.45 47.37 <0.0001
IPTG −152.19  46.54 −3.27 0.03
Kanamycin 8.61 46.54 0.18 0.86
IPTG ×Kanamycin 46.81 46.54 1.01 0.37IPTG −0.49  18.14 −0.03 0.98
Kanamycin −20.98  18.14 −1.17 0.31
IPTG × Kanamycin −24.79 18.14 −1.37 0.24
the ranges tested, since the p-value was  higher than 0.05 (Table 3).
This suggests that under the conditions tested the inducer concen-
tration could be reduced up to tenfold (also advantageous because
of its negative effect on cell growth) and kanamycin could even
be completely eliminated from the system without this having any
major impact on the protein concentration. Costs would be reduced
and expression levels would remain about the same.
Also, high concentrations of protein in a soluble form were
expressed in all the concentrations at 37 ◦C and 200 rpm, which is
positive, since E. coli normally expresses insoluble proteins under
such conditions. The concentration of ClpP obtained in these exper-
iments fell within the concentration range obtained in other studies
in the literature, which report on experiments to optimize the
expression of other proteins in E. coli using agitated ﬂasks and batch
cultivation [22,25–28].  Data from the literature show that higher
protein concentrations from E. coli are achieved when the heterol-
ogous protein is expressed and optimized in bioreactors, where
conditions can be controlled [26].
3.2.3. Effect of variables on plasmid segregation
Independent of the kanamycin concentration, the experiments
carried out using lower concentrations of IPTG yielded higher cell
growth than the others and greater plasmid stability, since the val-
ues for  ˚ (fraction of plasmid-bearing cells) in experiments 1 and 2
were higher than in the others. In the experiments with lower IPTG
concentrations, the fraction of plasmid-bearing cells was found to
be between 37% and 56%, while in the other experiments induced
with higher IPTG concentrations,  ˚ was  found to be lower than this.
In other words, in the experiments with lower IPTG concentrations
there was less plasmid segregation (Table 1).
The effects of the variables on  ˚ are shown in Table 4. It can
be concluded from these analyses, within a 95% conﬁdence inter-
val, that the IPTG concentration in the range tested had a negative
effect on plasmid stability, while the kanamycin concentration in
the system and the IPTG/kanamycin interaction had no appreciable
impact on  ˚ in the range under study. This means that the closer
the IPTG concentration was  to 0.1 mM,  the more plasmid stability
was  achieved for any kanamycin concentration within the range
under study.
The negative effect of induction with IPTG on plasmid seg-
regation identiﬁed in this study was already mentioned in the
literature [14,29,30].  Marí et al. [29] found that when they used vec-
tors pYMK5 and pYMK7, which contain brain-derived neurotrophic
factor (BDNF) and nerve growth factor (NGF) genes, respectively,
plasmid stability declined in the presence of the inducer (1 mM
IPTG) in E. coli, with or without the antibiotics ampicillin and
kanamycin. Data on the stability of plasmid pED-GnRH3 (obtained
from vector pET28a), transformed in E. coli, indicate that plasmid
segregation is far more dependent on induction than the pres-
Table 4
Effects of variables on  ˚ value (fraction of plasmid-bearing cells).
Effects Standard error t(4) p-value
Mean 0.19 0.04 4.34 0.01
IPTG −0.38 0.12 −3.10 0.03
Kanamycin 0.12 0.12 0.97 0.38
IPTG × Kanamycin −0.07 0.12 −0.56 0.61
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Fig. 3. Mean CFU/mL obtained from the experiments at the center point. (A) CFU/mL
in  LB agar plates without kanamycin. (B) CFU/mL in LB agar plates with kanamycin.140 K. Einsfeldt et al. / Va
nce or absence of kanamycin, and that after 10 h cultivation in
on-induced cultures, plasmid stability was as high as 95% with
ntibiotics and 90% without them. However, stability levels in
nduced cultures were far lower after 10 h induction, dropping as
ow as 15% with antibiotics and 10% without them [30].
If one looks at the values for  ˚ obtained in the experiments at
he center point (Table 1), one might think that the value obtained
n experiment 6 (CP) is an outlier since it differs from the trend
een for all the other  ˚ values from the replications performed
t the center point. An outlier is deﬁned as an experimental point
hat would seem not to ﬁt into a particular distribution pattern of
robabilities deﬁned by the vast majority of the other experimental
oints [18]. However, the identiﬁcation of outliers is a controver-
ial issue and the elimination of a putative outlier could result in a
isinterpretation of the data. For this reason, the effects of the vari-
bles on the plasmid-bearing cells (˚)  were analyzed both taking
ccount of and discarding the  ˚ value obtained from experiment 6
CP), resulting in the same conclusions about the effects.
Also, it can be perceived from the  ˚ values (fraction of plasmid-
earing cells) (Table 1) that the behavior of the  ˚ values was
ot linear, which was conﬁrmed by the low value of the linear
djustment coefﬁcient (R2). As it is only possible to assess linear
egression coefﬁcients for each variable when analyzing central
omposite design, the low R2 indicates that the linear model does
ot adjust well to the data. According to the studied ranges, in order
o obtain lower plasmid segregation levels, 0.1 mM IPTG should
e used. These data do not rule out the possibility of there being
n optimal point lower than 0.1 mM IPTG that would still assure
inimum plasmid segregation and good protein expression lev-
ls.
.2.4. Statistical analysis of the procedure (colony count and
erial dilution) for determining plasmid stability
The results of the statistical analysis showed that according to
he Student’s t-test, the mean CFU/mL values obtained from the
xperiments were equivalent, meaning that for most of the data
hey were statistically equivalent (within a 95% conﬁdence level), as
an be seen from Fig. 3. The only statistically different values were
he mean CFU/mL values obtained from aliquots 1 and 2 at dilution
1 (A1D1 and A2D1) from experiment 8, on the plates with and
ithout kanamycin, and the mean values for aliquot 1 at dilution
 and aliquot 2 at dilution 2 (A1D1 and A2D2) from experiment 8,
n the plates with kanamycin (Fig. 3). It can also be seen from Fig. 3
hat the conﬁdence intervals of the means for the D2 dilutions were
lways higher than those for the D1 dilutions, independent of the
liquots, showing that the variability of the mean for dilution D2
as higher than for dilution D1, which means that the errors made
n dilution D2 were greater than in D1.
When the variance in the data on CFU/mL was  assessed using
he F-test, when different aliquots with the same dilution were
ompared (Fig. 4A) the calculated F values were within the F value
imits for 95% conﬁdence, except when aliquots 1 and 2 at dilu-
ion D1 were compared (A1D1 and A2D1) from experiment 8 with
o antibiotic. This means that the errors incurred during the dilu-
ion and colony count procedures were the same when compared
etween the same dilutions. However, when different dilutions of
he same aliquot were compared, the data showed different vari-
nce levels in most cases (Fig. 4B). The calculated F values were
utside the pre-established F interval at 95% conﬁdence level. As
lready reported and shown in Fig. 3, the errors in the CFU/mL data
ere greater at dilution D2 than they were at dilution D1, with stan-
ard deviation about ten times higher in the data for dilution D2
han for dilution D1 (data not shown). This variability is owing to
he fact that at the higher dilution (D2), between 0 and 10 colonies
ere counted, while at D1, between 10 and 100 colonies were
ounted. This being the case, only the data on CFU/mL obtained fromVertical bars represented the conﬁdence intervals, with 95% conﬁdence level. The
symbols represent the different aliquots (A1 and A2) and their dilutions (D1 and D2)
for each experiment: A1D1 (), A2D1 (), A1D2 (), A2D2 ().
dilution D1 were used for calculating  ˚ values in the experimental
design experiments.
This statistical analysis shows that when the data from dilution
D1 were used, the procedures for determining plasmid stability
(serial dilutions and colony count) were reproducible, meaning that
the CFU/mL data obtained had statistically equivalents means and
variances, within a 95% conﬁdence interval.
3.3. Validation of experimental design
The optimal condition as identiﬁed by the experimental design
was  the condition used in experiment 1 (0.1 mM IPTG and 0 g/mL
kanamycin). This condition permitted a tenfold reduction in the
inducer concentration and the elimination of kanamycin from the
system, keeping the protein concentration and cell growth at sim-
ilar levels while also keeping plasmid stability at levels that would
not harm recombinant protein production over the 4 h expression
period.
In order to validate the optimal condition as identiﬁed by exper-
imental design, replications of the culture were produced under
this condition (0.1 mM  IPTG and 0 g/mL kanamycin). The cul-
tures were allowed to grow until they reached exponential growth
(Abs600 nm approximately 0.7), at which point they were induced
with 0.1 mM IPTG. From this moment on, samples were taken every
hour for analysis until the end of the 4 h induction period.
The mean cell growth (expressed as dry mass of cells – mg/L)
obtained for these replications was 912 mg  cells/L at the end of 4 h
induction, with 13.7% relative standard deviation, which is in agree-
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Fig. 4. F-test values for each experiment at the center point. Values for conﬁdence limits for the F-test at conﬁdence 95% (low limit – Log(F0.025) (- - -) and high limit –
Log(F0,975) (—)). (A) Comparison between different aliquots with the same dilutions; the symbols representing the values of the F-test obtained when comparing the data
on  the different aliquots at same dilutions for each experiment are as follows: A1D1 and A2D1(), A1D2 and A2D2 ( ); in this case the gray lines, ( ) and ( ),
represents the conﬁdence limits for comparison between A1D1 and A2D1(). (B) Comparison between different dilutions of one aliquot; the symbols representing the values
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wf  the F-test obtained when comparing the data on the different dilutions of one ali
ent with the ﬁnal value obtained for experiment 1 of the initial
xperimental design. Cell growth was also monitored throughout
he experiment and the graph of the cell growth rate is shown in
ig. 5A.
The analysis of cell growth (Fig. 5A) shows that after 2 h induc-
ion (242 min  of culture), the cells started to reach the stationary
rowth phase. Some authors argue that when systems with strong
romoters are used, as is the case of T7 promoters, when the system
s induced the growth rate drops because the host cell’s metabolism
s overburdened [31]. The speciﬁc growth rate obtained in this
tudy was 0.72 h−1 while the generation time was 0.96 h. Simi-
ar values to these have been obtained in other studies during the
xpression of heterologous proteins in E. coli [32].
The mean protein production over 4 h expression can be seen
n Fig. 5A, with this value reaching around 294 mg/L ClpP at the
nd of this period. This is slightly higher than the value obtained
n experiment 1 from the experimental design. However, taking
nto account the errors associated with the densitometry measure-
ents, which varied from 10% to 13% in these experiments, and the
stimated 8% error in experiment 1 from the experimental design,
t can be stated that the values obtained in the validation experi-
ent were similar to those obtained from the original experimental
esign experiment. It can be seen (Fig. 5A) that after the second
our of induction (242 min  of culture) the protein production rate
nd cell growth rate both started to fall, coming close to the sta-
ionary phase during the fourth hour of induction. It can therefore
e concluded that there would be nothing to be gained by extend-
ng the expression time further, since the protein concentration
ould remain constant and the overall productivity of the process
ould fall.or each experiment are as follows: A1D1 and A1D2(), A2D1 and A2D2 ( ).
By calculating the ratio of protein concentration to dry mass of
cells, the yield factor YP/X was obtained (production of product per
cell) throughout the induction time. The plasmid segregation in the
cultures was  also studied over time, starting from the moment pro-
tein expression was  induced. Fig. 5B shows the graph of variable ˚
(fraction of plasmid-bearing cells) and yield factor YP/X as a function
of culture time after induction. Fig. 5B shows that over 4 h expres-
sion the fraction of plasmid-bearing cells reached around 45%. The
great variability of the values calculated for  ˚ over the 242 min of
culture time could be associated with the physiological state of the
cells, since it was  at this point that the cell growth rate fell most
sharply (Fig. 5A). The system also presented plasmid segregation in
the negative control using E. coli BL21 (DE3) Star/pET28a.
The ˚ values obtained in these experiments were similar to
those obtained in a study that also used a pET vector in the
expression of recombinant phytase [33]. The authors reported that
stability levels had fallen to 10% by 4 h of induction. They added that
before induction the plasmid was  stable for over 96 h, but that after
induction it started to show signs of segregation. The greater level
of instability after induction could be attributed to the fact that
recombinant protein expression imposes a metabolic burden on
the host cells, resulting in higher segregation levels. Other authors
have also shown that vector pET101 is more stable in non-induced
cultures [34], showing that when the system is induced, plasmid
stability reaches around 30% when the pH is not controlled and
around 60% when the pH is kept at 7.0 after 4 h expression. These
results imply that the pH may  have been behind the low stability
levels seen in our study, since this factor was  not kept constant. In
the experiments to validate the optimal condition obtained from
factorial planning, the initial pH of the cultures was  7.0, but by the
7142 K. Einsfeldt et al. / Vaccine 2
Fig. 5. (A) ClpP concentration and dry mass of cells as a function of culture time.
The arrow indicates the time when expression started to be induced; () dry mass
of  cells (mg/L), ( ) ClpP concentration (mg/L). (B) Yield factor of ClpP to cell mass
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[1] Jedrzejas MJ.  Pneumococcal virulence factors: structure and function. MicrobiolYP/X) and fraction of plasmid-bearing cells (˚) as function of culture time; () ˚
fraction of plasmid-bearing cells), ( ) YP/X (mg  of ClpP/mg of dry cells).
nd of the 4 h expression period it had dropped to 5.1. There may  be
ther factors associated with the low plasmid stability found in our
xperiments, such as the drop in dissolved oxygen in the cultures,
hich some authors suggest could have an impact on plasmid sta-
ility [14]. As the experiments were conducted in agitated ﬂasks
nd this does not allow dissolved oxygen in the culture medium
o be controlled, this could have been one of the causes behind
he high segregation levels encountered throughout the culture
eriod. In order to control aeration, pH and monitor other process
ariables, bioreactors should be employed, as should experimental
esign tools to deﬁne the optimal operation conditions. Aside from
he factors presented here, there are many others that may  have an
mpact on plasmid stability. Some authors claim that more complex
ulture mediums may  result in lower plasmid stability [35]. The
ther factors that might affect stability are the growth rate, num-
er of plasmid copies, the insert size and the recombinant protein
xpression level [35].
The yield factor (YP/X), obtained throughout the culture time can
e seen in Fig. 5B. It can be seen that after the second hour of induc-
ion (242 min  of culture), the yield factor no longer increased at
he same rate, again indicating that longer expression times would
ring no particular beneﬁt. As expected, as segregation increased,
he product formation rate per dry mass of cells dropped and the
ield factor (YP/X) came close to constant levels (Fig. 5B). The yield
actor still increased even during the third and fourth hours of
xpression, albeit at a slower rate. This may  have been because
f the increased protein production by the remaining plasmid-
earing cells. In studies of phytase expression in E. coli [33] the
uthors found that in the ﬁrst 2 h of induction, phytase produc-
ion increased from 0 to 800 U/L while plasmid stability fell to 60%,9 (2011) 7136– 7143
i.e. even with 40% segregation, phytase production continued to
rise. After two  and a half hours’ induction, phytase production rose
again to 1000 U/L, while segregation increased to 80%. It was only
after this point that phytase activity started to drop [33]. The data
presented in Fig. 5 show that after 4 h induction the fraction of
plasmid-bearing cells stood at around 45%, while the yield factor
was  still rising. However, as shown by other authors [33], if seg-
regation were to rise even higher, the yield factor could start to
fall.
4. Conclusions
High levels of a soluble form of ClpP were expressed in all the
experiments from the experimental design used. Plasmid segre-
gation was  identiﬁed in the system throughout the kanamycin
concentration range tested. The lowest concentration of IPTG
(0.1 mM)  tested in this study resulted in greater plasmid stability.
The statistical analyses made of the procedures used to determine
plasmid segregation conﬁrmed that they are reproducible. By using
experimental design it was  possible to conclude that the optimal
point of the system was  with 0.1 mM IPTG and 0 g/mL kanamycin,
which yielded 247.3 mg/L ClpP; this optimal condition was vali-
dated with success. It should therefore be possible to reduce the
inducer concentration tenfold and eliminate the antibiotic from the
system while still keeping protein expression at similar levels and
reducing overall process costs. It is also important to highlight the
importance of the study of plasmid segregation in recombinant sys-
tems, since plasmid stability is one of the lynchpins of recombinant
protein production.
Experimental design proved to be a powerful tool for deter-
mining the optimal conditions for expressing recombinant protein
in E. coli using a minimum number of experiments, enabling an
assessment to be made of the effect of each of the variables, their
interactions and experimental errors. It is still common practice
in molecular biology for each variable to be evaluated separately,
which may  result in misinterpretations of the data obtained,
because it fails to take account of their interactions. Experimental
design enables the selection of the best test conditions for detecting
the interactions between the variables, which is not possible empir-
ically by adopting the methods usually used in the area that treat
variables independently. These techniques have universal applica-
tion in the production of recombinant proteins.
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